Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.62 - $0.86 $1,348 - $1,870
-2,175 Reduced 31.0%
4,840 $3,000
Q4 2023

Feb 13, 2024

SELL
$0.7 - $1.31 $1,672 - $3,129
-2,389 Reduced 25.4%
7,015 $5,000
Q3 2023

Nov 14, 2023

SELL
$1.25 - $3.0 $5,966 - $14,319
-4,773 Reduced 33.67%
9,404 $12,000
Q2 2023

Aug 21, 2023

BUY
$1.73 - $2.79 $24,526 - $39,553
14,177 New
14,177 $35,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.